Philip Chamberlain is the founder of Neomorph. Neomorph has raised $109M in total funding. Latest round: Series A. Backed by Deerfield.
Philip Chamberlain is the Co-Founder, President, and CEO of Neomorph, Inc., a biotechnology company he founded in 2020. The company, headquartered in San Diego, California, focuses on advancing a proprietary targeted protein degradation platform. He orchestrated a $109 million Series A financing round in December 2020 to further the company's protein degradation programs.
Full founder directory · Investor directory · Company funding database · Fundraising library